Pharmaceutical companies want to eliminate PBMs since they save patients a lot of money.
Senate Bill Targets Prescription Drug Pricing Recently, a bipartisan group of senators proposed new drug pricing laws aimed at addressing the role of pharmacy benefit managers (PBMs). Over the years, pharmaceutical companies have portrayed PBMs as villains in the prescription supply chain, arguing that these intermediary agents inflate prices and stifle innovation. This narrative is […]
See RFK Jr. target the pharmaceutical industry with a humorous drug advertisement.
Parody Video Targets Pharmaceutical Advertising In a recent move, Robert F. Kennedy Jr. and the Department of Health and Human Services introduced a parody video aimed at critiquing consumer-targeted pharmaceutical ads. This follows the unveiling of a new strategy focused on tackling misleading advertisements in the drug industry. The parody kicks off with a line […]
Health care expenses are rising significantly. Hold insurers, pharmaceutical companies, and your employer accountable.
In the United States, healthcare is quite costly, even by developed nations’ standards, and it seems prices are climbing even higher. About 154 million people receive health insurance through their employers, and many are noticing their deductions on paychecks spiking next year. Alongside this, out-of-pocket costs may also rise as employers look to offset the […]
Trump administration takes aim at major pharmaceutical companies for misleading drug promotions
Trump Administration Targets Misleading Drug Advertisements The Trump administration is working on new regulations to address loopholes that allow misleading drug advertisements to downplay safety risks in both broadcast and digital formats. On Tuesday, the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) sent out thousands of warning letters […]
Trump writes to pharmaceutical companies asking for reduced prescription costs
President Donald Trump has recently reached out to pharmaceutical companies in a letter, urging them to reduce drug prices, as outlined in an executive order signed in May. However, experts note that Trump’s capacity to compel these companies to lower their prices is limited, as his approach effectively constitutes price control. This strategy of applying […]
Trump calls on pharmaceutical companies to reduce drug prices within the next 60 days.
On Thursday, President Trump reached out to 17 of the largest pharmaceutical companies in the world, urging that more be done to lower prescription drug prices, aligning them with the lowest prices found in some foreign nations. This letter highlights a push to implement a “most preferred country” pricing model, which would base U.S. prescription […]
You’ve received $2 million from a pharmaceutical company.
Heated Exchange at House Hearing on Vaccines Health and Human Services Secretary Robert F. Kennedy Jr. had a tense confrontation with Rep. Frank Palone (D-NJ) during a House Energy and Commerce Committee hearing on Tuesday. Kennedy argued that Democrats had neglected vaccine-injured Americans after receiving contributions from pharmaceutical companies. During the hearing, which discussed the […]
Dr. Mccullough Uncovers a Potential Cancer Treatment That Major Pharmaceutical Companies Prefer to Keep Secret
The Covid-19 pandemic has changed how many Americans view healthcare. It has become clear that some health facilities prioritize profits from pharmaceuticals over the well-being of patients. This issue isn’t just about the pandemic. Unfortunately, the influence of profit on healthcare is a recurring theme in many aspects of medical practice. When discussing cancer treatment, […]
Pharmaceutical Company Purchases Failed DNA Collection Firm, Gaining Entry To World’s Largest Genetic Database
Regeneron to Acquire 23andMe for $256 Million Regeneron Pharmaceuticals, a U.S. biotechnology firm, has announced its acquisition of genetic testing company 23andMe following a winning bid of $256 million during a bankruptcy auction. This move comes as part of a broader strategy to enhance access to genetic data. The acquisition allows Regeneron to obtain a […]
Trump’s Drug Price Strategy and the Pharmaceutical Trade Conflict
Trump’s Drug Price Orders Challenge Foreign Free-Riding For many years, American consumers have faced some of the highest drug prices globally. The government has opted not to engage in negotiations. In contrast, other nations have instituted strict price caps and demanded significant discounts from pharmaceutical companies, while the US has permitted drug manufacturers to set […]